Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.47 |
| ▸ | CHAT | P28329 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6745095 | 0.93 | RAB9A (0.46) | RAB9ARCE1CHATMAPTPKM | |
| SCHEMBL6745098 | 0.90 | RAB9A (0.44) | RAB9ARCE1CHATMAPTPKM | |
| SCHEMBL6330866 | 0.79 | RAB9A (0.47) | RAB9ARCE1CHATMAPTPKM | |
| SCHEMBL2799728 | 0.78 | IDO1 (0.41) | MAPTMAPK1SMN1; SMN2IDO1EP300 | |
| SCHEMBL2335412 | 0.78 | RAB9A (0.42) | RAB9ARCE1CHATMAPTPKM | |
| Iodide SCHEMBL14740160 | 0.77 | KCNA3 (0.41) | RAB9ARCE1CHATMAPTPKM | |
| SCHEMBL11073608 | 0.76 | LMNA (0.39) | RAB9ARCE1MAPTPKMMAPK1 | |
| SCHEMBL30611103 | 0.74 | RAB9A (0.69) | RAB9ARCE1CHATMAPTPKM | |
| SCHEMBL30894444 | 0.72 | MAPT (0.55) | RAB9ARCE1CHATMAPTPKM | |
| SCHEMBL1049804 | 0.72 | MAPT (0.55) | RAB9ARCE1CHATMAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6977001-B2 | Dye compositions containing quinolinium salts | WELLA AG (DE) | 2005-12-20 | — | — | US | claimed |
| US-20030196281-A1 | 1-benzopyrane-derivatives and colouring agents containing the salts thereof | WELLA AKTIENGESELLSCHAFT (DE) | 2003-10-23 | — | — | US | claimed |
| US-20030177592-A1 | Dye compositions containing quinolinium salts | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2003-09-25 | — | — | US | claimed |
| US-6977001-B2 | Dye compositions containing quinolinium salts | WELLA AG (DE) | 2005-12-20 | — | — | US | disclosed |
| US-20030196281-A1 | 1-benzopyrane-derivatives and colouring agents containing the salts thereof | WELLA AKTIENGESELLSCHAFT (DE) | 2003-10-23 | — | — | US | disclosed |
| US-20030177592-A1 | Dye compositions containing quinolinium salts | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2003-09-25 | — | — | US | disclosed |
| EP-1121858-A2 | Agent for discouraging feeding activities of animals | Horn, Gert, Dipl.-Ing. agr. (DE) | 2001-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030196281-A1 | 1-benzopyrane-derivatives and colouring agents containing the salts thereof | KRT18, COL2A1, PHB1 | RAB9A 4719/4885RCE1 4122/4885CHAT 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.